|
Volumn 25, Issue 6, 2017, Pages 987-988
|
Immune-mediated inflammation as a driver of obesity and comorbid conditions
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GAMMA INTERFERON;
INDOLEAMINE 2,3 DIOXYGENASE;
INDOLEAMINE 2,3 DIOXYGENASE 1;
LEPTIN;
UNCLASSIFIED DRUG;
ABDOMINAL FAT;
ADIPOCYTE;
BODY MASS;
CALORIC INTAKE;
CANCER RISK;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CELLULAR IMMUNITY;
CYTOKINE PRODUCTION;
CYTOKINE RELEASE;
DIET RESTRICTION;
ENERGY EXPENDITURE;
ENZYME ACTIVITY;
EXERCISE;
FAT MASS;
GRIP STRENGTH;
HORMONE RELEASE;
HUMAN;
IMMUNE MEDIATED INFLAMMATION;
IMMUNOPATHOLOGY;
IMMUNOREACTIVITY;
INFLAMMATION;
MACROPHAGE ACTIVATION;
MORTALITY RISK;
NOTE;
OBESITY;
PREVALENCE;
SATIETY;
SEROTONIN RELEASE;
TH1 CELL;
WAIST CIRCUMFERENCE;
HUMANS;
INFLAMMATION;
OBESITY;
|
EID: 85019844251
PISSN: 19307381
EISSN: 1930739X
Source Type: Journal
DOI: 10.1002/oby.21872 Document Type: Note |
Times cited : (6)
|
References (5)
|